<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03679663</url>
  </required_header>
  <id_info>
    <org_study_id>TASMC-18-CFW-0219-CTIL</org_study_id>
    <nct_id>NCT03679663</nct_id>
  </id_info>
  <brief_title>Ultrasound Versus Palpation for Spinal Anesthesia Success</brief_title>
  <acronym>Accuro</acronym>
  <official_title>Prospective Randomized Controlled Trial to Compare a Handheld Ultrasound Identification of the Neuraxial Block Insertion Site Versus Palpation Only in an Obese Population of Women Undergoing Cesarean Delivery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim is to investigate the difference in number of attempts to place neuraxial block comparing&#xD;
      handheld ultrasound versus use of palpation alone for women with impalpable bony landmarks&#xD;
      undergoing spinal anesthesia for elective cesarean delivery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be recruited prior to cesarean delivery and their site of lumbar injection will&#xD;
      be examined. Women with impalpable bony landmarks will be offered recruitment to the study.&#xD;
      Women will be randomly assigned to the standard of care group - palpation attempts only,&#xD;
      versus an ultrasound group, where the insertion point will be identified by the handheld&#xD;
      ultrasound device&#xD;
&#xD;
      Inclusion criteria:&#xD;
&#xD;
      Lumbar spinous processes impalpable. Elective cesarean delivery for singleton pregnancies BMI&#xD;
      &gt;30 No contraindications to neuraxial block Signed informed consent Neuraxial Block planned&#xD;
      Exclusion Criteria Refuses informed consent Poor written Hebrew, no spoken English or Hebrew&#xD;
      Patients will be randomized into two groups : an ultrasound (US) group and a palpation (PP)&#xD;
      group.&#xD;
&#xD;
      The primary outcome of our study is the number of needle redirections, defined as any ventral&#xD;
      advancement of the needle and/or introducer, as well as any new intervertebral space&#xD;
      attempted.&#xD;
&#xD;
      Secondary outcomes include:&#xD;
&#xD;
      The insertion site identification time, patient verbal numerical pain score (0-10) after skin&#xD;
      incision.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 20, 2018</start_date>
  <completion_date type="Actual">August 4, 2020</completion_date>
  <primary_completion_date type="Actual">August 4, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>RCT</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The outcomes will be assessed by an observer who was not in the room when the puncture site was identified and was blinded to the study group. The room set up will be identical with the handheld ultrasound placed visible in all cases, including those randomized to the palpation group.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Needle movement</measure>
    <time_frame>10 mins</time_frame>
    <description>number of needle redirections, defined as any ventral advancement of the needle and/or introducer, as well as any new intervertebral space attempted.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The insertion site identification time,</measure>
    <time_frame>10 mins</time_frame>
    <description>time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient verbal numerical pain score (0-10) after skin incision.</measure>
    <time_frame>10 mins</time_frame>
    <description>Patient verbal numerical pain score (0-10) after skin incision. Scale is Verbal numerical rating scale, where zero = no pain at all and 10 = maximum possible pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient verbal numerical pain score (0-10) after spinal performance. Patient verbal numerical pain score (0-10). Scale is Verbal numerical rating scale, where zero = no pain at all and 10 = maximum possible pain.</measure>
    <time_frame>10 mins</time_frame>
    <description>Patient verbal numerical pain score (0-10) after spinal performance. Patient verbal numerical pain score (0-10) Scale is Verbal numerical rating scale, where zero = no pain at all and 10 = maximum possible pain.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Ultrasound</condition>
  <arm_group>
    <arm_group_label>Palpation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Anesthesia performed without ultrasound</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultrasound</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Anesthesia performed after ultrasound</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound</intervention_name>
    <description>Use of ultrasound to identify pre-puncture site</description>
    <arm_group_label>Ultrasound</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Lumbar spinous processes impalpable. Elective caesarean delivery for singleton pregnancies&#xD;
        BMI &gt;30 No contraindications to neuraxial block Signed informed consent Neuraxial Block&#xD;
        planned&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tel Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>September 17, 2018</study_first_submitted>
  <study_first_submitted_qc>September 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 20, 2018</study_first_posted>
  <last_update_submitted>October 2, 2020</last_update_submitted>
  <last_update_submitted_qc>October 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ultrasound</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

